When Standard Is Not Enough: A Narrative Review of Supratherapeutic SSRI Doses in Resistant Obsessive Compulsive Disorder.

While these between-group differences did not reach statistical significance after adjusting for baseline differences in mood and anxiety, patients in the higher-dose group demonstrated greater mean reductions in Y-BOCS scores and better outcomes across multiple secondary measures.

also in 111,027 other papers